OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study
Isabel Hurtado, Celia Robles, Salvador Peiró, et al.
Diabetologia (2024) Vol. 67, Iss. 11, pp. 2471-2480
Open Access | Times Cited: 8
Isabel Hurtado, Celia Robles, Salvador Peiró, et al.
Diabetologia (2024) Vol. 67, Iss. 11, pp. 2471-2480
Open Access | Times Cited: 8
Showing 8 citing articles:
Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study
Samantha B. Shapiro, Hui Yin, Oriana Hoi Yun Yu, et al.
BMJ (2025), pp. e080679-e080679
Closed Access | Times Cited: 1
Samantha B. Shapiro, Hui Yin, Oriana Hoi Yun Yu, et al.
BMJ (2025), pp. e080679-e080679
Closed Access | Times Cited: 1
The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Measures of Suicidality A Systematic Review
K.L. Valentino, Kayla M. Teopiz, William W. L. Cheung, et al.
Journal of Psychiatric Research (2025) Vol. 183, pp. 112-126
Open Access
K.L. Valentino, Kayla M. Teopiz, William W. L. Cheung, et al.
Journal of Psychiatric Research (2025) Vol. 183, pp. 112-126
Open Access
GLP-1 receptor agonists and suicidality
Peter Ueda, Björn Pasternak
BMJ (2025), pp. r351-r351
Closed Access
Peter Ueda, Björn Pasternak
BMJ (2025), pp. r351-r351
Closed Access
Beyond metformin: the expanding landscape of Type 2 diabetes treatment
Keith Ntokozo Ncube, T D Malange
SA pharmaceutical journal. (2025) Vol. 92, Iss. 1, pp. 30-34
Closed Access
Keith Ntokozo Ncube, T D Malange
SA pharmaceutical journal. (2025) Vol. 92, Iss. 1, pp. 30-34
Closed Access
The effect of GLP-1RAs on mental health and psychotropics-induced metabolic disorders: A systematic review
Sigrid Breit, Daniela Hubl
Psychoneuroendocrinology (2025), pp. 107415-107415
Closed Access
Sigrid Breit, Daniela Hubl
Psychoneuroendocrinology (2025), pp. 107415-107415
Closed Access
Association of GLP‐1 Receptor Agonists With Risk of Suicidal Ideation and Behaviour: A Systematic Review and Meta‐Analysis
Ganesh Bushi, Mahalaqua Nazli Khatib, Shivam Rohilla, et al.
Diabetes/Metabolism Research and Reviews (2025) Vol. 41, Iss. 2
Open Access
Ganesh Bushi, Mahalaqua Nazli Khatib, Shivam Rohilla, et al.
Diabetes/Metabolism Research and Reviews (2025) Vol. 41, Iss. 2
Open Access
Risk of Suicide From GLP-1 Agonists: Weighing Risks and Benefits
Andrew A. Nierenberg
Psychiatric Annals (2024) Vol. 54, Iss. 9
Closed Access
Andrew A. Nierenberg
Psychiatric Annals (2024) Vol. 54, Iss. 9
Closed Access
Obesity in children: inheritance and treatment – state of art 2024
Małgorzata Wójcik, Agnieszka Zachurzok
Pediatric Endocrinology Diabetes and Metabolism (2024) Vol. 30, Iss. 3, pp. 112-115
Open Access
Małgorzata Wójcik, Agnieszka Zachurzok
Pediatric Endocrinology Diabetes and Metabolism (2024) Vol. 30, Iss. 3, pp. 112-115
Open Access
Glucagon-like peptide-1-Rezeptoragonisten: Suizid- und Selbstverletzungsrisiko
Diabetologie und Stoffwechsel (2024) Vol. 19, Iss. 06, pp. 407-407
Closed Access
Diabetologie und Stoffwechsel (2024) Vol. 19, Iss. 06, pp. 407-407
Closed Access
